(Q44553655)

English

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

scientific article published on 18 August 2003

Statements

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial (English)
Jose C Nicolau
Thomas G Filloon
Christopher F Mojcik
COMPLY Investigators
18 August 2003
1176-1183

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit